Navigation Links
Unilens Vision Reports Increased Royalty Income
Date:5/28/2008

21st Consecutive Profitable Quarter Earns $.08 Per Diluted Share

LARGO, Fla., May 28 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2008.

Net sales, excluding royalty income, for the quarter ended March 31, 2008 increased to $1,668,397 compared with $1,634,429 in the prior-year quarter ending March 31, 2007 an increase of 2.1%. The increase was primarily the result of continued growth of the Company's C-Vue multifocal contact lenses, which increased approximately 11% in the current quarter, which was partially offset by sales of our replacement products lines that declined as expected.

Royalty income for the quarter increased 15.3% to $628,993 compared with $545,293 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued double digit royalty income growth.

For the quarter, the Company reported net income of $368,730, or $0.08 per diluted share, compared with net income of $372,355 or $0.08 per diluted share in the prior-year quarter.

For the nine months ended March 31, 2008, net sales excluding royalty income, increased 3.8% to $4,854,119 as compared to $4,677,358 for the prior- year period. Net sales of the Company's C-Vue multifocal contact lenses increased approximately 12% during the first nine months of fiscal year 2008, while sales of replacement products lines declined, as expected.

Net Income for the nine months increased 24.2% to $1,121,941, or $0.25 per diluted share, compared with $903,697, or $0.20 per diluted share in the prior-year period.

Royalty income for the nine months ended March 31, 2008 increased 21.1% to a record $1,888,641, compared with $1,559,496 in the prior-year period, demonstratin
'/>"/>

SOURCE Unilens Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
4. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
5. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
6. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
7. IMTEC Introduces New Vision Software
8. Delray Beach Soccer Club Signs Division One College Soccer Coaches
9. Lutein and Zeaxanthin Improve Sports Vision for Athletes
10. World Vision Appealing for $2 Million for Deadly China Quake
11. AVMA Declares Preliminary Victory on Farm Bill Provisions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...n, DC The study of tobacco has been the life-long... deputy director of the Lombardi Comprehensive Can..., has led the effort to edit a special-edition of ...EBP ) dedicated to best research practices in toba...he December issue of CEBP , a journal of the Amer...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Renal Disea...://www.reportlinker.com/p0166824/Renal-Disease-Tre...ts for the U.S. market in products and services, p... projections for the market and compound annual gr...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Antibiotic ...kets ,, http://www.reportlinker.com/p0166825/...Global-Markets.html ,, Provide an in-depth rev...e and antibiotics technologies ,, Offer an anal...
(Date:12/2/2009)...ovement seen for advanced cases, study finds , ...the past two decades, survival rates for advanced ...roved modestly, a new study has found. , Resear...diagnosed with stage 4 non-small cell lung cancer ...tion was in the U.S. National Cancer Institute,s S...
(Date:12/2/2009)...ecially likely to have metabolic syndrome, study f...ws) -- Exercise alone isn,t enough to keep overwei...risk for a medical condition that can lead to hear...studied linemen at Division I colleges and found t...d metabolic syndrome, a group of conditions that r...
Breaking Medicine News(10 mins):Health News:Lombardi's Shields leads special journal focused on tobacco research 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:Gains Made in Lung Cancer Survival 2Health News:Oversized College Football Players May Face Heart Risks 2
...l Lobby Congress to Sponsor the Congenital Heart F... Congenital Heart Disease Registry, Congenital Hea.... 9 The Children,s Heart Foundation (CHF) - the c...Day on February 10. The day unites organizations t...
...ON, Feb. 9 Hailed by Television Week for provid...les -- a 30-minute public affairs television prog...ories of real patients -- expanded this week into ... on nearly 260 television stations across the Unit...
...o Improve Your Heart Health Through Proper Oral Ca...rican Heart Month, women throughout the U.S. will ...health. To help support this national initiative a...l focus on empowering women by providing the knowl...
...ial Records Contradict Explanation That Home Was F...ccording to a story broken last night on TheWrap.C...of the Motion Picture and Television Foundation,s ... live out their lives at the facility. , , The st...
..., Families, Caregivers and Individuals at risk are...event it and to successfully manage and live with ...14, 2009 , , Heart Failure Society of America... set for February 8-14. This is a time for physi...
...INGTON, Feb. 9 Global multiservice public relatio...sent a live panel discussion,titled "Healthcare Co...Risks,in a Highly Regulated Environment." The pres...strom.com/reg/events/healthcare-webcast.aspx . , ...
Other Medicine News:Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 2Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 3Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 2Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 3Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 4Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 5Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 6Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 2Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 3Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 4Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 2Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 3Health News:Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2
(Date:12/2/2009)... , ABBOTT PARK, Ill., Dec. 2 /PRNewswire-Firs...nd characterizing a vast array of microorganisms h...y The Scientist magazine. A panel of expert jud...logies to determine the year,s top innovations, wi...ber issue and online at www.the-scien t ist.co...
(Date:12/2/2009)... , LEXINGTON, Mass. and HEIDELBERG, Ger... been recognized as one of the winners of the "Top...ne. The company,s automated sequence capture techn...due to its exceptional combinations of invention, ...d a panel of expert judges to evaluate a broad ran...
(Date:12/2/2009)... , KNOXVILLE, Tenn., Dec. 2 /PRNewswire/ ...com ), a division of the nation,s largest provider... it has signed two contracts to provide teleradiol...Illinois. ,, An agreement signed with UpState C...ll allow TeamHealth Teleradiology to provide servi...
Breaking Medicine Technology:Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist 2The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Federal stimulus funds support studies geared to improving HIV care and prevention 60794 1Federal stimulus funds support studies geared to improving HIV care and prevention 60794 2Near vision research study 60792 1Near vision research study 60792 2Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy 28SRT 29 in Diabetic Macular Edema 28DME 29 60791 1Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy 28SRT 29 in Diabetic Macular Edema 28DME 29 60791 2Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy 28SRT 29 in Diabetic Macular Edema 28DME 29 60791 3Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy 28SRT 29 in Diabetic Macular Edema 28DME 29 60791 4Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy 28SRT 29 in Diabetic Macular Edema 28DME 29 60791 5Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy 28SRT 29 in Diabetic Macular Edema 28DME 29 60791 6
...ation at the Associated Professional Sleep ...MORE, June 11 Data was presented today at the 22n...eep Societies (APSS),demonstrating that within 20 ...tigational low-dose, sublingual formulation of zol...significantly greater than that produced,by a swal...
...ethods, ROCKVILLE, Md., June 11 EntreMed, Inc.,(...ompany developing,therapeutics for the treatment o...d the issuance of U.S. Patent No. 7,371,741 coveri...nt grants EntreMed composition-of-matter,and metho...2025 for analogs,of 2ME2 in oncology and a broad r...
Other Medicine Technology:Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 2Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 3Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 4Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 5EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 2EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 3
Fascial Incising Needles
Mitty-Pollack Needle Set - Standard
Light Guide Cables - 2.0mm
3mm Universal Light Guide
Medicine Products: